Jon has been reporting on stock markets for over twenty-five years for audio text companies (remember them?!), newswires, and websites. He helped set up MarketEye News for ICV/Topic in the 1990’s before moving on to become a Markets reporter at AFX News. After over 10 years, which saw him rise to the dizzy heights of Markets Editor at AFX, the firm’s acquisition by Thomson Corp and subsequent takeover of Reuters, he moved on in 2012. Prior to Proactive Investors, he was News Editor for thisismoney.co.uk, the Mail Online’s financial website.
While Ocado has lowered its direct exposure to the Grocery Home Delivery model through its recently announced joint venture with M&S, it has not changed the fundamental economics which HSBC believes are challenged
Stephen O'Hara, OptiBiotix’s CEO commented: "Achieving FSSAI approval so quickly is a significant achievement and is an important step in completing the supply chain"
The FTSE 250-listed retirement homebuilder saw its pre-tax profit for the six months ended 28 February 2019 drop by 66% to £3.6mln, down from £10.5mln a year earlier
The AIM-listed firm said the additional coverage will open up access to a further 1,500 hospitals and 32,500 alternative care providers, primarily in the South Eastern region of the US
Moataz Karmalawy has served as general manager of the Worldwide Particle Therapy Business for Varian Medical Systems, the world's largest manufacturer of radiotherapy equipment for 12 years
Indivior’s chief scientific officer, Christian Heidbreder commented: "RECOVER is assessing real-world outcomes in patients for up to two years after they completed our clinical phase 3 Sublocade study"
The FTSE 250-listed firm said Paul Sandland, its EU finance director, will assume the role of acting CFO, with the search for a permanent successor already begun
The Peel Hunt analysts noted stronger traction than expected with the US Department of Defence (DoD), with the group having received a second order of the DoD in January